Kenneth G. Payie
United States of America
Dr. Ken Payie has almost a decade in the large pharma industry in a variety of research and development positions. With a background in large and small molecule Chemistry Manufacturing & Controls (CM&C) development, virtual drug development experience, and Six Sigma black belt execution, Dr. Payie has developed a number of large and small molecule CM&C programs in the Candidate Identification to Phase II space for both large pharma and small drug discovery companies. Dr. Payie has designed and directed drug development programs through outsourcing to Asia, Europe and North American vendors, and dramatically reduced costs to develop assets without compromising Quality. In 2011, Dr. Payie founded KGP-Biotech Consulting LLC to bring his expertise to the scientific and drug development communities. In addition to his involvement with KGP and Confluence, Dr. Payie has held senior positions at Chorus Europe, Vanthys Pharmaceutical Development and Eli Lilly.